Interestingly, plenty of studies have reported an amplification of the GARP gene in tumours, especially in those with an invasion or metastatic potential, suggesting a role of this gene product in regulating aggressive tumour biology, once deregulated.18, 19, 20. The gene discussed is LRRC32; the disease is neoplasm.